- Patent Title: Agents useful in treating facioscapulohumeral muscular dystrophy
-
Application No.: US16562030Application Date: 2019-09-05
-
Publication No.: US10907157B2Publication Date: 2021-02-02
- Inventor: Alexandra Belayew , Frederique Coppee , Celine Vanderplanck , Stephen Donald Wilton , Eugenie Ansseau
- Applicant: Universite de Mons
- Applicant Address: BE Mons
- Assignee: Universite de Mons
- Current Assignee: Universite de Mons
- Current Assignee Address: BE Mons
- Agency: Knobbe Martens Olson & Bear LLP
- Priority: EP10175125 20100902
- Main IPC: C12N15/11
- IPC: C12N15/11 ; C12N15/113
Abstract:
Antisense agents and RNA interference agents useful for treating diseases and conditions the treatment of which can benefit from reducing the expression of double homeobox 4 and/or double homeobox 4c, more particularly facioscapulohumeral muscular dystrophy, are described. Methods, uses and further products employing such agents are also described.
Public/Granted literature
- US20200231966A1 AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY Public/Granted day:2020-07-23
Information query
IPC分类:
